Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-10

Clinical Trial Update: Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

View source ↗

Summary

This trial update discusses a terminated study evaluating voriconazole trough levels, pharmacogenomics, efficacy, and safety in patients with invasive fungal in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VFEND (Voriconazole)

Snippet

Sponsor: Asan Medical Center | Conditions: Invasive Fungal Infection | Status: TERMINATED